1. A Quantitative Modeling and Simulation Framework to Support Candidate and Dose Selection of Anti‐SARS‐CoV‐2 Monoclonal Antibodies to Advance Bamlanivimab Into a First‐in‐Human Clinical Trial. Issue 3 (17th November 2021) Authors: Chigutsa, Emmanuel; Jordie, Eric; Riggs, Matthew; Nirula, Ajay; Elmokadem, Ahmed; Knab, Tim; Chien, Jenny Y. Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 3(2022) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development and Qualification of a Drug‐Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials. Issue 4 (1st February 2018) Authors: Gaitonde, Puneet; Hurtado, Felipe K.; Garhyan, Parag; Chien, Jenny Y.; Schmidt, Stephan Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 4(2018) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development and Verification of a Body Weight–Directed Disease Trial Model for Glucose Homeostasis. (7th September 2020) Authors: Farhan, Nashid; Gebert, Ines; Xing, Yifan; Wieser, Katharina; Lingineni, Karthik; Ma, Xiaosu; Chien, Jenny Y.; Garhyan, Parag; Schmidt, Stephan Journal: Journal of clinical pharmacology Issue: Volume 61:Number 2(2021) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PK/PD modeling links accelerated resolution of COVID‐19‐related clinical symptoms to SARS‐CoV‐2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together. (5th April 2022) Authors: Ernest, C. Steven; Chien, Jenny Y.; Patel, Dipak R.; Chigutsa, Emmanuel Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 6(2022) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗